Neuroprotective Effects of B-Type Cinnamon Procyanidin Oligomers on MPP<sup>+</sup>-Induced Apoptosis in a Cell Culture Model of Parkinson’s Disease

Cinnamon procyanidin oligomers (CPOs) are water-soluble components extracted from cinnamon. This study aims to explore the neuroprotection of B-type CPO (CPO-B) against 1-methyl-4-phenylpyridinium (MPP<sup>+</sup>)-mediated cytotoxicity and the molecular mechanisms underlying its protect...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Qi Xu, Ziyu Chen, Borong Zhu, Yiming Li, Manju B. Reddy, Huilin Liu, Guodong Dang, Qi Jia, Xiaojun Wu
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/1b914925553a455e842eb64b3033b9bc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Cinnamon procyanidin oligomers (CPOs) are water-soluble components extracted from cinnamon. This study aims to explore the neuroprotection of B-type CPO (CPO-B) against 1-methyl-4-phenylpyridinium (MPP<sup>+</sup>)-mediated cytotoxicity and the molecular mechanisms underlying its protection. The results demonstrated that CPO-B showed protection by increasing cell viability, attenuating an intracellular level of reactive oxygen species, downregulating cleaved caspase-3 expression, and upregulating the Bcl-2/Bax ratio. Moreover, CPO-B completely blocked the dephosphorylation of extracellular, signal-regulated kinase 1 and 2 (Erk1/2) caused by MPP<sup>+</sup>. Treatment with an Erk1/2 inhibitor, SCH772984, significantly abolished the neuroprotection of CPO-B against MPP<sup>+</sup>. Taken together, we demonstrate that CPO-B from cinnamon bark provided protection against MPP<sup>+</sup> in cultured SH-SY5Y cells, and the potential mechanisms may be attributed to its ability to modulate the dysregulation between pro-apoptotic and anti-apoptotic proteins through the Erk1/2 signaling pathway. Our findings suggest that the addition of cinnamon to food or supplements might benefit patients with PD.